Notably, five of the six patients who relapsed within 1 year after surgery were classified as having T cell–deserted tumors on-treatment, and all patients with NSCLC exhibited low CD4+ T cell densities within the tumor core (Fig. 6E). This evidence concerns the gene CD4 and non-small cell lung carcinoma.